CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.71
-0.25 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
25.70
-0.04%
After-hours: Aug 15, 2025, 04:54 PM EDT
CG Oncology Common stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -128.08M | -105.56M | -88.04M | -72.8M | -64.16M | -56.87M | -48.61M | -40.44M | -28.68M | -17.06M | -8.39M |
Depreciation & Amortization | 201K | 52K | 32K | 27K | 11K | 8K | 8K | 17K | 12K | 8K | 4K |
Stock-Based Compensation | 19.8M | 15.04M | 11.4M | 7.19M | 4.93M | 2.87M | 1.53M | 898K | 504K | 327K | 148K |
Other Working Capital | 15.18M | 9.87M | 230K | -2.09M | -6.25M | -9.43M | 768K | 1.11M | 1.5M | 1.5M | 1.12M |
Other Non-Cash Items | -3.16M | -3.28M | -5.01M | -8.71M | -6.79M | -3.69M | -1.37M | 1.18M | 853K | 232K | 107K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 17.43M | 11.77M | 2.91M | 172K | -3.04M | -5.76M | 3.02M | 2.16M | 1.96M | 1.68M | 1.3M |
Operating Cash Flow | -93.82M | -81.98M | -78.71M | -74.11M | -69.04M | -63.7M | -45.68M | -36.45M | -25.6M | -14.81M | -6.83M |
Capital Expenditures | -238K | -238K | -234K | -25K | -20K | -12K | n/a | 1K | -5K | 1K | 1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -916.15M | -954.54M | -1.05B | -1.21B | -1.23B | -1.06B | -682.57M | -358.44M | -166.38M | -134.04M | -55.34M |
Sales Maturities Of Investments | 799.94M | 799.69M | 745.41M | 517.23M | 346.65M | 312.24M | 166.37M | 166.37M | 135.71M | n/a | n/a |
Other Investing Acitivies | -26M | -25M | n/a | 396.42M | 395.01M | 395.01M | 316.31M | -135.45M | -134.04M | -134.04M | -55.34M |
Investing Cash Flow | -142.45M | -180.09M | -300.76M | -294.73M | -489.53M | -349.94M | -121.19M | -193.47M | -30.68M | -134.04M | -55.34M |
Debt Repayment | 365K | 365K | n/a | -366K | -433K | -15.82M | -16.29M | -16.29M | -16.22M | -833K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -661K | -365K | -3.75M | -6.28M | 99.67M | 99.83M | 103.29M | 106.18M | 233K | 68K | n/a |
Financial Cash Flow | 225.74M | 226.07M | 628.28M | 401.98M | 505.69M | 490.42M | 87M | 146.58M | 40.71M | 55.93M | 56.7M |
Net Cash Flow | -10.53M | -36M | 248.8M | 33.14M | -52.88M | 76.78M | -79.88M | -83.34M | -15.57M | -92.92M | -5.47M |
Free Cash Flow | -94.06M | -82.22M | -78.95M | -74.14M | -69.06M | -63.72M | -45.68M | -36.45M | -25.61M | -14.81M | -6.83M |